Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Management of Drug-Induced Parkinsonism

Clinical Presentation and Diagnosis

  • Clinical presentation of drug-induced parkinsonism typically includes bradykinesia, tremors, and rigidity that may be difficult to distinguish from negative symptoms of schizophrenia, according to the American Academy of Child and Adolescent Psychiatry 1

Management Algorithm

  • When antipsychotics are necessary, consider switching to an agent with lower risk of drug-induced parkinsonism, such as quetiapine or clozapine, as recommended by Pharmacological Research 2
  • Regular assessment using standardized scales like the Abnormal Involuntary Movement Scale (AIMS) is recommended every 3-6 months, as suggested by the American Academy of Child and Adolescent Psychiatry 1

Special Considerations

  • In patients with psychiatric conditions requiring antipsychotics, balance the risk of psychotic relapse against the severity of parkinsonian symptoms, according to Pharmacological Research 2

Prevention

  • Baseline and periodic assessment using standardized scales is recommended, as suggested by the American Academy of Child and Adolescent Psychiatry 1

Management of Drug-Induced Parkinsonism

Symptomatic Treatment

  • Anticholinergic medications such as trihexyphenidyl may be used for mild to moderate symptoms, particularly effective for tremor and rigidity, with an initial dose of 1 mg daily and total daily dosage usually ranging between 5-15 mg, according to the American Academy of Child and Adolescent Psychiatry 3
  • The American Academy of Child and Adolescent Psychiatry recommends using anticholinergic agents carefully in elderly patients due to potential cognitive side effects 3